Why methotrexate suboptimal dosing is a potential source of bias in biologic drugs clinical trials. [electronic resource]

By: Contributor(s): Producer: 20180808Description: e53 p. digitalISSN:
  • 1468-2060
Subject(s): Online resources: In: Annals of the rheumatic diseases vol. 75
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Comment

There are no comments on this title.

to post a comment.